Americans Encounter Risks at Psychedelic Clinics Abroad
- Posted on August 26, 2026
- Psychedelic And Hallucinogenic Drugs
- By The New York Times
- 1 Views
- 1 min read
Thousands of Americans travel annually to psychedelic retreats in foreign countries seeking therapeutic benefits from substances like psilocybin and ayahuasca. However, these unregulated clinics operate in legal gray areas with minimal oversight, leaving vulnerable participants exposed to inadequate medical supervision, unqualified practitioners, and psychological harm. When injuries or exploitation occur, patients face significant barriers to legal recourse and have limited protection under international law, creating a concerning gap in patient safety standards.
Summary auto-generated by AI from the original publisher's content. Editorial standards.
Americans Encounter Risks at Psychedelic Clinics Abroad
Participants, often in vulnerable states, have little recourse if mistreated or injured. continue reading...